Analytica 2024: An Interview with Michael Lämmerhofer
During Analytica 2024 in Munich, Germany, Michael Lämmerhofer of the University of Tuebingen discusses the potential of chiral stationary phases (CSPs) in different applications.
Michael Lämmerhofer is a full professor (W3) for pharmaceutical (bio-)analysis at the University of Tübingen, Germany. H earned his PhD in Pharmaceutical Chemistry at the University of Graz, Austria. He was coworker of Professor W. Lindner (University of Vienna, Austria) until 2011 and from 1999 to 2000 he was post-doc at the Department of Chemistry of the University of California, Berkeley, USA, with Prof Frantisek Svec.
His research interests include the development of functionalized separation materials (chiral stationary phases, mixed‑mode phases, chemo- and bioaffinity materials, nanoparticles, monoliths), metabolomics and lipidomics, pharmaceutical analysis (impurity profiling, enantioselective analytics), multidimensional separations, and biopharmaceuticals analysis.
In this interview segment, Lämmerhofer discusses the following questions:
- Tell us a little bit about your presentation at Analytica.
- Chiral stationary phases (CSPs) are commonly associated with enantiomeric separation of chiral drugs. What other applications can they be used in?
- When it comes to real bioanalytical applications, chromatographic selectivity is usually combined with mass spectrometry (MS) to cope with assay-specificity limitations of CSPs. Can you describe some applications when combining CSPs with MS benefits the analyst?
- What benefits can incorporating CSPs into multidimensional chromatography offer the analyst and can you also illustrate this with some practical examples?
- What are you most looking forward to from the conference this week?
To learn more about Analytica 2024, you can watch more of our team's videos from the festival, where we interview people like Elia Psillakis of Technical University of Crete and Anne Bendt of the Singapore Lipidomics Incubator (SLING).
TD-GC–MS and IDMS Sample Prep for CRM to Quantify Decabromodiphenyl Ether in Polystyrene Matrix
April 26th 2024At issue in this study was the certified value of decabromodiphenyl ether (BDE 209) in a polystyrene matrix CRM relative to its regulated value in the EU Restriction of Hazardous Substances Directive.
LC–MS/MS-Based System Used to Profile Ceramide Reactions to Diseases
April 26th 2024Scientists from the University of Córdoba in Córdoba, Spain recently used liquid chromatography–tandem mass spectrometry (LC–MS/MS) to comprehensively profile human ceramides to determine their reactions to diseases.
High-Throughput 4D TIMS Method Accelerates Lipidomics Analysis
April 25th 2024Ultrahigh-pressure liquid chromatography coupled to high-resolution mass spectrometry (UHPLC-HRMS) had been previously proposed for untargeted lipidomics analysis, but this updated approach was reported by the authors to reduce run time to 4 min.
